Company intelligence / Profile preview

Osteotech

Eatontown, New Jersey, United Statesosteotech.pt ↗

Ownership: Private
Development stage: Other

Overview

Osteotech was a global leader in processing human bone and connective tissue for transplantation. The company developed innovative biologic, biomaterial, and device systems for musculoskeletal surgery with a focus on spinal, trauma, and total joint revision procedures. Its key products included Grafton demineralized bone matrix and MagniFuse bone grafts. In August 2010, Osteotech was acquired by Medtronic.

Therapeutic areas: NeurologyRheumatologyOther
Modalities: BiologicBiomaterialDevice
Industry: Implantable Medical Devices

Partnerships

Musculoskeletal Transplant Foundation (MTF)

Beyond the preview

Go deeper on Osteotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteotech.

Explore the full profile